# CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients

> **NCT00999713** · PHASE2,PHASE3 · COMPLETED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 43 (actual)

## Conditions studied

- Acute Lung Injury

## Interventions

- **DRUG:** Calfactant
- **OTHER:** Air placebo

## Key facts

- **NCT ID:** NCT00999713
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2015-09
- **Final completion:** 2015-10
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00999713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00999713, "CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00999713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*